None
Conditions
Interventions
Observation group (treatment with compound sulfamethoxazole):None
Sponsors
Tongde Hospital of Zhejiang Province
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >=18 years; 2.Non-HIV patients or SMA infection patients with imaging, etiological and molecular biological results suggesting PJP; 3.Receiving TMP-SMZ injection treatment; 4.Agreeing to participate in this study and signing the informed consent form;
Exclusion criteria
Exclusion criteria: 1.Those known to be allergic to TMP-SMZ; 2.Those who have used TMP-SMZ for less than 3 days; 3.Patients who do not cooperate with blood collection and related tests at the specified time; 4.Pregnant or lactating women; 5.Other situations where the researcher deems the patient unsuitable for participation in this clinical trial;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical efficacy;Microbial clearance; | — |
Secondary
| Measure | Time frame |
|---|---|
| Economic indicators (length of stay, total hospitalization cost, total hospitalization examination cost, total hospitalization drug cost, total hospitalization antibiotic cost, compound sulfamethoxazole cost);Survival and recurrence of infection;Adverse reactions; | — |
Countries
China
Contacts
Public ContactYuexing Tu
Tongde Hospital of Zhejiang Province
Outcome results
None listed